Polypeptide comprising cell-penetrating sequence and composition comprising same
The present application provides: a polypeptide characterized by having an ability of penetrating into a cell and the structure represented by Formula (I) wherein n is a number of 2 to 20; R 1 and R 2 may independently represent a C 1 -C 4 alkyl group or may bind to each other to form a ring; R 3 represents a C 1 -C 10 primary aminoalkyl group; R 4 represents a hydrogen atom or a C 1 -C 10 hydrocarbon group; the “n” number of R 1 , R 2 , R 3 , and R 4 may independently be the same with or different from each other; and the N-terminus and the C-terminus may or may not be modified independently; and a cell-invasive composition comprising the polypeptide and a substance of interest.
1. A polypeptide having cell-penetrating ability and represented by Formula (I):
wherein n is 3; R 1 and R 2 represent a methyl group; R 3 represents a 4-aminobutyl group; R 4 represents a methyl group; and the N terminus and/or the C terminus of the polypeptide comprise a reactive functional group(s) capable of forming a complex between a cargo molecule and the polypeptide;
wherein the C terminus is modified by a C 1 -C 10 alkoxy group or a C 1 -C 10 monoalkylamino or dialkylamino group; and
wherein the N terminus is modified by an acyl group, —C═O—R where R represents a C 1 -C 10 alkyl group, an alkoxycarbonyl group, —C═O—OR where R represents a C 1 -C 10 alkyl group, or a C 1 -C 10 alkyl group in which one or more carbon atoms in the carbon chain may be substituted with an oxygen, nitrogen, or sulfur atom(s).
2. The polypeptide according to claim 1 , wherein the reactive functional group is a maleimide-containing modification group or a thiol-containing modification group.
3. A kit for intracellular delivery comprising the polypeptide according to claim 1 .
4. A cell-invasive composition comprising a polypeptide, as a first polypeptide, according to claim 1 and a substance of interest, wherein the substance of interest is united with the polypeptide or is present independently from the polypeptide.
5. The composition according to claim 4 , wherein the substance of interest is selected from the group consisting of a protein, a peptide, a glycoprotein, a naturally-occurring or non-naturally-occurring nucleic acid, DNA, RNA, a DNA/RNA hybrid, an oligonucleotide, a polynucleotide, an anti-sense molecule, miRNA, siRNA, a plasmid, a low-molecular-weight compound, a sugar, a lipid, a glycolipid, a contrast substance, a drug, nanoparticles, and a quantum dot.